Group Cognitive Behavioural Family Intervention (CBFI) for People With Schizophrenia and Their Families

NCT04065360 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-03-31

No results posted yet for this study

Summary

Cognitive behavioural family intervention (CBFI) is a brief psychosocial intervention that incorporates the model of cognitive behavioural therapy (CBT) into the family context. It builds upon the current trend of family interventions/psychoeducation with refocusing on the cognitive model within the family interpersonal relationship. Existing literature indicates that CBFI may be effective in improving positive and negative symptoms of people diagnosed with schizophrenia immediately following the programme. This mixed-method is to evaluate the feasibility and effectiveness of a CBFI programme for people with schizophrenia and their families in a local context. The findings may accumulate more evidence that CBFI is a brief and effective psychosocial intervention that is adapted to Hong Kong clinical settings.

Conditions

Interventions

BEHAVIORAL

Group Cognitive behavioural family intervention (CBFI)

four-week, four-session CBT-based family intervention programme

BEHAVIORAL

Usual group psychoeducation

Treatment as usual in the institution studied

Sponsors & Collaborators

  • The University of Hong Kong

    collaborator OTHER
  • Hospital Authority, Hong Kong

    lead OTHER_GOV

Principal Investigators

  • Chak Fai Ma, MSc · Kwai Chung Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-31
Primary Completion
2021-10-31
Completion
2022-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04065360 on ClinicalTrials.gov